AVENUE THERAPEUTICS INC (ATXI)
Institutional ownership reported to the SEC as of Q4 2024, across 25 quarters.
Institutions report 192,628 shares against 1,911,633 outstanding. Shares only - option lines are excluded, which is why this can be compared with the company at all. The count comes from the cover page of the company's own most recent report, so it is dated when that was filed rather than at quarter end. Share count carried from an earlier filing (cy2024q3i).
Calls and puts are the parts of reported value carried in derivative lines rather than shares, and they point in opposite directions: a manager holding calls is positioned for the security, one holding puts against it - or hedging shares they already own, which is why index funds carry so many. Most sites add the two together and report one figure, which averages away the only interesting part.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Ikarian Capital, LLC | $280.0K | 140,000 | 0.04% | new | NEW |
| BOOTHBAY FUND MANAGEMENT, LLC | $82.2K | 41,089 | 0.00% | new | NEW |
| UBS Group AG | $15.8K | 7,920 | 0.00% | 3q | +28.9%+$3.6K |
| Tower Research Capital LLC (TRC) | $6.2K | 3,096 | 0.00% | 3q | +77.9%+$2.7K |
| WELLS FARGO & COMPANY/MN | $1.0K | 500 | 0.00% | 3q | -10.9% |
| BANK OF AMERICA CORP /DE/ | $28 | 14 | 0.00% | 3q | +40.0% |
| SBI Securities Co., Ltd. | $18 | 9 | 0.00% | new | FIRST |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2024 | 7 | $385.3K | 192,628 | 2 | 3 | 1 | 0.0% |
| Q3 2024 | 8 | $491.8K | 197,516 | 1 | 5 | 1 | 0.0% |
| Q2 2024 | 8 | $407.2K | 116,350 | 8 | 0 | 0 | 0.0% |
| Q1 2024 | 13 | $168.9K | 1,150,825 | 4 | 4 | 1 | 0.0% |
| Q4 2023 | 14 | $52.4K | 324,311 | 5 | 2 | 3 | 0.0% |
| Q3 2023 | 13 | $157.3K | 222,620 | 4 | 1 | 3 | 0.0% |
| Q2 2023 | 11 | $849.4K | 727,606 | 1 | 2 | 2 | 0.0% |
| Q1 2023 | 13 | $532.7K | 456,748 | 6 | 1 | 2 | 0.0% |
| Q4 2022 | 13 | $520.5K | 448,813 | 7 | 4 | 0 | 0.0% |
| Q3 2022 | 10 | $766.0K | 75,920 | 10 | 0 | 0 | 0.0% |
| Q2 2022 | 16 | $181.0K | 672,752 | 4 | 2 | 7 | 0.0% |
| Q1 2022 | 14 | $503.0K | 1,040,837 | 1 | 6 | 3 | 0.0% |
| Q4 2021 | 15 | $2.1M | 2,361,854 | 2 | 5 | 5 | 0.0% |
| Q3 2021 | 18 | $1.6M | 1,088,894 | 4 | 5 | 4 | 0.0% |
| Q2 2021 | 25 | $2.9M | 1,149,746 | 9 | 3 | 11 | 0.0% |
| Q1 2021 | 33 | $11.1M | 1,835,613 | 3 | 9 | 9 | 0.0% |
| Q4 2020 | 35 | $12.2M | 2,055,305 | 8 | 14 | 6 | 0.0% |
| Q3 2020 | 33 | $29.7M | 2,744,268 | 3 | 10 | 13 | 0.0% |
| Q2 2020 | 36 | $28.1M | 2,612,751 | 20 | 11 | 2 | 0.0% |
| Q1 2020 | 20 | $17.6M | 1,965,386 | 9 | 6 | 1 | 0.0% |
| Q4 2019 | 14 | $15.7M | 1,636,925 | 3 | 6 | 3 | 0.0% |
| Q3 2019 | 15 | $8.7M | 1,452,790 | 4 | 4 | 4 | 0.0% |
| Q2 2019 | 12 | $8.6M | 1,363,573 | 1 | 5 | 3 | 0.0% |
| Q1 2019 | 13 | $5.5M | 1,159,432 | 6 | 3 | 2 | 0.0% |
| Q4 2018 | 7 | $3.7M | 688,200 | 0 | 0 | 0 | 0.0% |